NMPA Approval

Recombinant Human Follitropin Prefilled Syringe

Approval Number

国药准字SJ20210007

Registration Date

April 7, 2021

Drug Information

Generic Name

重组人促卵泡激素注射液

Trade Name

芳乐舒

Dosage Form

注射剂

Strength

225IU(0.45ml)/支

Drug Type

生物制品

Registration Date

April 7, 2021

Expiry Date

April 6, 2026

Company Address

129, Seokam-ro, Iksan-si, Jeollabuk-do, Republic of Korea

Company Address

129, Seokam-ro, Iksan-si, Jeollabuk-do, Republic of Korea

Empowering clinical research with data-driven insights and AI-powered tools.

重组人促卵泡激素注射液 - NMPA 批准文号 | MedPath